Cancer Supportive Care Products Market Size | COVID-19 Impact Analysis | Forecast to 2030 - PowerPoint PPT Presentation

About This Presentation

Cancer Supportive Care Products Market Size | COVID-19 Impact Analysis | Forecast to 2030


Cancer Supportive Care Products Market 2020 Analysis and Review: Cancer Supportive Care Products Market by Indication – Lung Cancer, Prostate Cancer, Melanoma et al for 2020-2030 – PowerPoint PPT presentation

Number of Views:73
Slides: 10
Provided by: Umesh213
Category: Other


Transcript and Presenter's Notes

Title: Cancer Supportive Care Products Market Size | COVID-19 Impact Analysis | Forecast to 2030


Cancer Supportive Care Products Market COVID-19
Impact Analysis, Share, Demand, Growth, Expert
Review Forecast by 2030 FMI
  • May 2021

Report Id REP-GB-2550Published On  
2020-07-30Category Healthcare, Pharmaceuticals
Medical Devices
AboutFuture Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage
  • Customized Research
  • Syndicated Research
  • Investment Research
  • Social Media Research

  • Automotive and Transportation
  • Electronics, Semiconductor, and ICT
  • Retail and Consumer Products
  • Industrial Automation and Equipment
  • Chemicals Materials
  • Food and Beverages
  • Services and Utilities
  • Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email
Research Methodology (1/2)
  • Systematic Research Approach

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
FMI formulates a detailed discussion guide to conduct expert and industry interviews
FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts
FMI conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
FMI delivers industry insights and information in the required format (PDF)
  • Identifying key opinion leaders
  • Questionnaire design
  • In-depth interviews
  • Coverage across value chain
  • Key industry experts
  • Channel study
  • Developments
  • Market dynamics
  • Products
  • Conclusions

  • Market participants
  • Key strengths
  • Product portfolio
  • Mapping as per value chain
  • Key focus segments

Primary Research
Secondary Research
Paid Publications
  • Linkedin
  • Zoominfo
  • Salesforce
  • Avention
  • Factiva
  • GBI
  • Genios
  • Meltwater
  • Company websites
  • Company annual reports
  • White papers
  • Financial reports

includes sources of databases
Cancer Supportive Care Products Market Analysis
The cancer supportive care products market is
anticipated to reach a valuation of US 32
billion by 2030. The industry is expected to be
marginally impacted by the ongoing crisis of the
coronavirus outbreak. The critical nature of
cancer treatment is a key factor that supports
the production and sales of cancer supportive
care products. On the other hand, potential risks
of coronavirus on immunocompromised cancer
patients can create challenges in the
industry. As the FMI report foresees the future
of the cancer supportive care products market,
the demand will expand at a notable CAGR of
during the forecast period of 2020 to 2030. In
terms of revenue, the concerned market is poised
to attain a valuation of US 32 Bn by the end of
2030, Cancer supportive care products market is
expected to grow at about 4 y-o-y in 2020. As
per the World Cancer Research Fund International
(WCRF), it has been projected that there will be
more than 24 million cases of cancer by 2035
globally. These numbers do not include
non-melanoma skin cancer. According to the
National Cancer Institute (NIH), there were more
than a million cancer cases in the U.S.
itself Most prominent cancer treatment
therapies have been known to cause a wide range
of potentially serious side effects.
Consequently, the role of cancer supportive care
drugs is essential in reducing such side effects.
So, increasing incidences of cancer has a direct
impact on the growth of this market for the
foreseeable future, says the report by FMI.
Cancer Supportive Care Products Market Analysis
  • Cancer Supportive Care Products Market Primary
  • Erythropoietin stimulating agents are accounting
    for major market share, owing to superior
    efficacy in supporting the patients immunity
    capacities during treatment.
  • Supportive care for breast cancer is rapidly
    gaining ground, supported by high investments by
    private and public bodies toward breast cancer
    awareness campaigns.
  • North America is a major market for cancer
    supportive care products, aided by favorable
    reimbursement policies, and better healthcare
  • Download a Sample Report with Table of Contents
    and Figures https//
  • Cancer Supportive Care Products Market Growth
  • Steadily rising incidences of cancer, coupled
    with higher incomes and better healthcare
    facilities are key driving factors.
  • High investments by governments and healthcare
    companies towards product development support

Cancer Supportive Care Products Market Analysis
  • Cancer Supportive Care Products Market Major
  • The increasing use of targeted therapy drugs for
    cancer reduces side effects and the requirement
    of supportive care products.
  • Strict regulations and slow approval of cancer
    supportive care products holds back market
  • For information on the Research Approach used in
    the Report, Request Methodology_at_ https//www.futur

Cancer Supportive Care Products Market Analysis
The Projected Impact of Coronavirus With the
high level of contagiousness of the covid-19
virus, healthcare facilities are being forced to
balance the need for cancer therapies, with the
potential risk of severe complications arising
from a coronavirus infection, particularly as
most cancer patients are immunocompromised for
the duration of the treatment. Supportive care
products which can minimize clinic and hospital
visits are gaining preference. As a result,
telehealth options are likely to gain ground
during the pandemic. Competition Landscape The
cancer supportive care products market comprises
players including but not limited to Teva
Pharmaceutical Industries Ltd., Amgen Inc.,
Fagron, Johnson Johnson Pvt. Ltd., Hoffmann La
Roche Ltd., Baxter, Novartis AG, Heron Pharma,
Bendalis Gmbh, Enlivity Corporation, and ARIAD
Pharmaceuticals. Participants in the cancer
supportive care products market are largely
displaying interest in setting up clinical
trials, and acquiring regulatory approval for new
offerings in development.
Cancer Supportive Care Products Market Analysis
For instance, Pfizer announced the FDA approval
for Bavencio avelumab for supportive care in
advanced bladder cancer. Similarly, Specialized
Therapeutics Asias NERLYNX for early breast
cancer care has received approval by the National
Pharmaceutical Regulatory Agency of Malaysia.
Javelin Pharmaceutical Inc. has set up a
promising clinical trial for second-line
immunotherapy for its bladder cancer supportive
care drug. Request Special Price for this Report
to our Sales Executive_at_ https//www.futuremarketin
To know more about us, please visit our website For sales queries
or new topics email us on sales_at_futuremarketinsi For media queries, contact the press
office at For
other queries contactHari. T (Sr. Manager -
Global Business Development) Future Market
Insights 3rd Floor,207 Regent Street, London
W1B 3HH T 44 20 7692 8790 D 44 20 3287
4268 Email
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)
Write a Comment
User Comments (0)